(NASDAQ:AFYA) operates in the education sector, providing educational services in Brazil with a focus on medical education, including undergraduate and graduate courses. AFYA competes with other educational institutions like Grand Canyon Education ((NASDAQ:LOPE)), and both are considered potential value stocks in the schools sector.
On April 1, 2026, AFYA's CEO, Gibbon Virgilio Deloy Capobianco, sold 19,500 shares of Class A Common Share at $14.98 each. This transaction follows a previous sale of 3,900 shares at $15.18 per share, totaling $59,202. Despite these sales, Capobianco retains a significant stake, holding 130,118 shares in the company.
AFYA’s stock performance shows a slight decrease, with the latest trading session opening at $14.75, a 1.3% drop. The stock’s 50-day simple moving average is $14.39, while the 200-day average is $14.74, indicating a stable yet slightly declining trend in recent months.
Financially, AFYA presents a compelling case for investors. The company holds a Zacks Rank of #1 (Strong Buy), suggesting a strong earnings outlook. Its price-to-earnings (P/E) ratio is approximately 9.18, indicating a favorable market valuation of its earnings. The price-to-sales ratio is about 1.87, reflecting its market value relative to revenue.
AFYA’s financial health is further supported by its enterprise value to sales ratio of 2.41 and an enterprise value to operating cash flow ratio of 6.11. These metrics suggest a reasonable market valuation compared to its sales and cash flow. With a debt-to-equity ratio of 0.64 and a current ratio of 2.20, AFYA maintains a moderate debt level and strong liquidity, ensuring it can cover short-term liabilities effectively.
